Page 109 - Memoria FEHH - SEHH 2017
P. 109

  PROGRAMA ESPAÑOL DE TRATAMIENTOS EN HEMATOLOGÍA (PETHEMA)
MEMORIA ANUAL 2017
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
• Rodríguez Otero P, Mateos MV, Joaquín ML, Hernández MT, Ocio E, Rosinol L, Martínez R, Teruel AI, Gutiérrez NC, Oriol A, Martín-Calvo N, Paiva B, Bargay J, Bengoechea E, González Y, Pérez de Oteyza J, Gironella M, Encinas C, Martín J, Cabrera C, Palomera L, de Arriba F, Cedena MT, Puig N, Bladé J, Lahuerta JJ, San Miguel JF. Predictors of early death related to active multiple myeloma in elderly patients receiving optimized frontline treatment combinations. 22th Congress of the EHA 2017. Madrid, June 2017. Haematologica. 2017 Jun 11;102(s2):P688.
• Conde M, Alcoceba M, Jiménez C, García-Álvarez M, Sarasquete ME, Balanzategui A, Corral R, Marín L, Ramos F, Godoy A, Barez A, Gutiérrez NC, García-Sanz R, González-Diaz M, Chillón MC. Mutational profile of relapse-risk groups in acute promyelocytic leukemia patients. 22th Congress of the EHA 2017. Madrid, June 2017. Haemato- logica. 2017 Jun 11;102(s2):E887.
• Onecha De La Fuente E, Rapado I, Cedena MT, Llops M, Ruiz-Heredia Y, García Vela JA, Pérez Oteyza J, Figuera A, Penalver FJ, Barragán E, Gallardo M, Martínez-López J, Ayala R. MRD analysis by next-generation sequencing ap- proach for acute myeloid leukemia follow-up. 22th Congress of the EHA 2017. Madrid, June 2017. Haematologica. 2017 Jun 11;102(s2):E891.
• Onecha De La Fuente E, Rapado I, Llops M, Ruiz-Heredia Y, Cedena MT, Barragán E, Gallardo M, Martínez López J, Ayala R. NGS analysis and impact of variant allelic frequency at relapse and refractoriness status in aml pa- tients. 22th Congress of the EHA 2017. Madrid, June 2017. Haematologica. 2017 Jun 11;102(s2):E899.
• López Anglada L, Fernández, Cueto-Felqueroso C, Mateos MV, Rosinol L, Oriol A, Teruel AI, Palomera L, Arriba F, Bar- gay J, Hernández JM, González Y, María Jesús B, Valeri A, Granell M, García Sanz R, López de la Guía A, Besalduch J, Martínez RB , Hernández MT, Puerta P, Blade J, San Miguel J, Lahuerta JJ, Martínez-López J. Serum-free light- chains (SFLC) instead of urine protein electrophoresis (UPEP) for monitoring light-chain multiple myeloma (LCMM). 22th Congress of the EHA 2017. Madrid, June 2017. Haematologica. 2017 Jun 11;102(s2):E1278.
• Genescà E, Lazarenkof A, Morgades M, Berbis G, Ruíz-Xivillé N, Gómez-Marzo P, Ribera J, Mercadal S, Guardia R, Artola MT, Moreno MJ, Martínez-López J, Zamora L, Barba P, Gil C, Tormo M, Cladera A, Novo A, Esteve J, González- Campos J, Almeida M, Cervera JV, Montesinos P, Granada I, Batlle M, Vives S, Feliu E, Orfao A, Solé F, Ribera JM. Frequency and clinical impact of CDKN2A/B gene locus in an adult T-all cohort of patients enrolled in the spanish Pethema group protocols. 22th Congress of the EHA 2017. Madrid, June 2017. Haematologica. 2017 Jun 11;102(s2):PB1616.
• Sánchez-Vega B, Mateos MV, Cuenca I, Puig N, Barrio S, Ruiz-Heredia X, Aguirre, Ayala R, Rosinol L, Blade J, Ma- teos MV, García-Sanz R, San Miguel J, Lahuerta JJ, Martínez-López J. Detection of new emerging clones during treatment by NGS allows a better risk prediction on multiple myeloma patients. 22th Congress of the EHA 2017. Madrid, June 2017. Haematologica. 2017 Jun 11;102(s2):P679.
• Leivas A, Rapado I, Fernández L, Pérez-Martínez A, Lahuerta JJ, Martínez-López J. Activated and expanded natural killer cells from multiple myeloma patients destroy tumor drug resistant cells and clonogenic tumor cells. 22th Congress of the EHA 2017. Madrid, June 2017. Haematologica. 2017 Jun 11;102(s2):E1234.
• San Miguel J, Echeveste Gutiérrez MA, Špicka I, Mateos MV, Song K, Craig M, Blade J, Hajek R, Chen C, Gupta N, Byrne C, Lu V, van de Velde H, Lonial S. The oral proteasome inhibitor ixazomib in combination with mel- phalan-prednisone for patients with newly diagnosed multiple myeloma: phase 1/2 dose-escalation study (NCT01335685). 22th Congress of the EHA 2017. Madrid, June 2017. Haematologica. 2017 Jun 11;102(s2):P339.
• Ordóñez R, Kulis M, Russinol N, Beekman R, Meydan C, Verdaguer-Dot N, Carrasco A, Ezponda T, Martens JH, Stunnenberg HG, Paiva B, San Miguel J, Melnick A, Campo E, Prosper F, Agirre X, Martín-Subero JI. Multilayer epig-
109
 



















































































   107   108   109   110   111